Abstract

Background and purpose

The CATCH (Coil Application Trial in China) trial was designed to assess the safety and efficacy of the Numen Coil Embolization System in the treatment of intracranial aneurysms in comparison with the Axium coil (ev3/Medtronic). Although the endovascular treatment of small (< 5 mm) intracranial aneurysms has been reported with favorable long-term clinical and angiographic outcomes, randomized trials are still lacking. Data for aneurysms smaller than 5 mm were extracted from the CATCH trial.

Materials and methods

A randomized, prospective, multicenter trial was conducted at ten centers throughout China. Enrolled subjects with small intracranial aneurysms were randomly assigned to receive treatment with the Numen Coil or the Axium coil. The primary outcome was successful aneurysm occlusion at the 6-month follow-up. In contrast, the secondary outcomes included complete aneurysm occlusion, recurrence rate, clinical deterioration, and safety data at the 6-month and 12-month follow-ups.

Results

A total of 124 patients were enrolled in the study. Overall, 58 patients were assigned to the Numen group, and 66 were assigned to the Axium group. At the 6-month follow-up, the successful aneurysm occlusion rate was 93.1% (54/58) in the MicroPort NeuroTech group and 97.0% (64/66) in the Axium group, with a common odds ratio of 0.208 (95% confidence interval, 0.023–1.914; P = 0.184). Complications were comparable between the groups.

Conclusions

Compared with the Aixum coil, the Numen coil is safe and effective in treating small intracranial aneurysms.

Trial registration

(13/12/2016, NCT02990156)

Details

Title
Randomized, prospective, multicenter trial assessing the numen coil embolization system in the endovascular treatment of small intracranial aneurysms: outcomes from the CATCH Trial
Author
Jin, Yazhou; Guo, Xinbin; Quan, Tao; Zhao, Rui; Li, Tianxiao; Zhao, Zhenwei; Yang, Hua; Zhu, Xingen; Liang, Guobiao; Leng, Bing; Wu, Xin; Wang, Yang; Guan, Sheng
Pages
1-7
Section
Research
Publication year
2023
Publication date
2023
Publisher
BioMed Central
e-ISSN
14712482
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2827038849
Copyright
© 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.